Biocompatibility of Liposome Nanocarriers in the Rat Inner Ear After Intratympanic Administration

Abstract Liposome nanocarriers (LPNs) are potentially the future of inner ear therapy due to their high drug loading capacity and efficient uptake in the inner ear after a minimally invasive intratympanic administration. However, information on the biocompatibility of LPNs in the inner ear is lackin...

Full description

Bibliographic Details
Main Authors: Jing Zou, Hao Feng, Rohit Sood, Paavo K. J. Kinnunen, Ilmari Pyykko
Format: Article
Language:English
Published: SpringerOpen 2017-05-01
Series:Nanoscale Research Letters
Subjects:
Online Access:http://link.springer.com/article/10.1186/s11671-017-2142-5
_version_ 1797713559215407104
author Jing Zou
Hao Feng
Rohit Sood
Paavo K. J. Kinnunen
Ilmari Pyykko
author_facet Jing Zou
Hao Feng
Rohit Sood
Paavo K. J. Kinnunen
Ilmari Pyykko
author_sort Jing Zou
collection DOAJ
description Abstract Liposome nanocarriers (LPNs) are potentially the future of inner ear therapy due to their high drug loading capacity and efficient uptake in the inner ear after a minimally invasive intratympanic administration. However, information on the biocompatibility of LPNs in the inner ear is lacking. The aim of the present study is to document the biocompatibility of LPNs in the inner ear after intratympanic delivery. LPNs with or without gadolinium-tetra-azacyclo-dodecane-tetra-acetic acid (Gd-DOTA) were delivered to the rats through transtympanic injection. The distribution of the Gd-DOTA-containing LPNs in the middle and inner ear was tracked in vivo using MRI. The function of the middle and inner ear barriers was evaluated using gadolinium-enhanced MRI. The auditory function was measured using auditory brainstem response (ABR). The potential inflammatory response was investigated by analyzing glycosaminoglycan and hyaluronic acid secretion and CD44 and TLR2 expression in the inner ear. The potential apoptosis was analyzed using terminal transferase (TdT) to label the free 3′OH breaks in the DNA strands of apoptotic cells with TMR-dUTP (TUNEL staining). As a result, LPNs entered the inner ear efficiently after transtympanic injection. The transtympanic injection of LPNs with or without Gd-DOTA neither disrupted the function of the middle and inner ear barriers nor caused hearing impairment in rats. The critical inflammatory biological markers in the inner ear, including glycosaminoglycan and hyaluronic acid secretion and CD44 and TLR2 expression, were not influenced by the administration of LPNs. There was no significant cell death associated with the administration of LPNs. The transtympanic injection of LPNs is safe for the inner ear, and LPNs may be applied as a drug delivery matrix in the clinical therapy of sensorineural hearing loss.
first_indexed 2024-03-12T07:38:19Z
format Article
id doaj.art-6ba091f065b5482e92f8443ba718e336
institution Directory Open Access Journal
issn 1931-7573
1556-276X
language English
last_indexed 2024-03-12T07:38:19Z
publishDate 2017-05-01
publisher SpringerOpen
record_format Article
series Nanoscale Research Letters
spelling doaj.art-6ba091f065b5482e92f8443ba718e3362023-09-02T21:26:04ZengSpringerOpenNanoscale Research Letters1931-75731556-276X2017-05-0112111410.1186/s11671-017-2142-5Biocompatibility of Liposome Nanocarriers in the Rat Inner Ear After Intratympanic AdministrationJing Zou0Hao Feng1Rohit Sood2Paavo K. J. Kinnunen3Ilmari Pyykko4Department of Otolaryngology Head and Neck Surgery, Center for Otolaryngology-Head and Neck Surgery of Chinese PLA, Changhai Hospital, Second Military Medical UniversityHearing and Balance Research Unit, Field of Oto-laryngology, School of Medicine, University of TampereHelsinki Biophysics and Biomembrane Group, Department of Biomedical Engineering and Computational Sciences, Aalto UniversityHelsinki Biophysics and Biomembrane Group, Department of Biomedical Engineering and Computational Sciences, Aalto UniversityHearing and Balance Research Unit, Field of Oto-laryngology, School of Medicine, University of TampereAbstract Liposome nanocarriers (LPNs) are potentially the future of inner ear therapy due to their high drug loading capacity and efficient uptake in the inner ear after a minimally invasive intratympanic administration. However, information on the biocompatibility of LPNs in the inner ear is lacking. The aim of the present study is to document the biocompatibility of LPNs in the inner ear after intratympanic delivery. LPNs with or without gadolinium-tetra-azacyclo-dodecane-tetra-acetic acid (Gd-DOTA) were delivered to the rats through transtympanic injection. The distribution of the Gd-DOTA-containing LPNs in the middle and inner ear was tracked in vivo using MRI. The function of the middle and inner ear barriers was evaluated using gadolinium-enhanced MRI. The auditory function was measured using auditory brainstem response (ABR). The potential inflammatory response was investigated by analyzing glycosaminoglycan and hyaluronic acid secretion and CD44 and TLR2 expression in the inner ear. The potential apoptosis was analyzed using terminal transferase (TdT) to label the free 3′OH breaks in the DNA strands of apoptotic cells with TMR-dUTP (TUNEL staining). As a result, LPNs entered the inner ear efficiently after transtympanic injection. The transtympanic injection of LPNs with or without Gd-DOTA neither disrupted the function of the middle and inner ear barriers nor caused hearing impairment in rats. The critical inflammatory biological markers in the inner ear, including glycosaminoglycan and hyaluronic acid secretion and CD44 and TLR2 expression, were not influenced by the administration of LPNs. There was no significant cell death associated with the administration of LPNs. The transtympanic injection of LPNs is safe for the inner ear, and LPNs may be applied as a drug delivery matrix in the clinical therapy of sensorineural hearing loss.http://link.springer.com/article/10.1186/s11671-017-2142-5NanomaterialLiposomeDrug DeliveryInner EarAnimalBiological Response
spellingShingle Jing Zou
Hao Feng
Rohit Sood
Paavo K. J. Kinnunen
Ilmari Pyykko
Biocompatibility of Liposome Nanocarriers in the Rat Inner Ear After Intratympanic Administration
Nanoscale Research Letters
Nanomaterial
Liposome
Drug Delivery
Inner Ear
Animal
Biological Response
title Biocompatibility of Liposome Nanocarriers in the Rat Inner Ear After Intratympanic Administration
title_full Biocompatibility of Liposome Nanocarriers in the Rat Inner Ear After Intratympanic Administration
title_fullStr Biocompatibility of Liposome Nanocarriers in the Rat Inner Ear After Intratympanic Administration
title_full_unstemmed Biocompatibility of Liposome Nanocarriers in the Rat Inner Ear After Intratympanic Administration
title_short Biocompatibility of Liposome Nanocarriers in the Rat Inner Ear After Intratympanic Administration
title_sort biocompatibility of liposome nanocarriers in the rat inner ear after intratympanic administration
topic Nanomaterial
Liposome
Drug Delivery
Inner Ear
Animal
Biological Response
url http://link.springer.com/article/10.1186/s11671-017-2142-5
work_keys_str_mv AT jingzou biocompatibilityofliposomenanocarriersintheratinnerearafterintratympanicadministration
AT haofeng biocompatibilityofliposomenanocarriersintheratinnerearafterintratympanicadministration
AT rohitsood biocompatibilityofliposomenanocarriersintheratinnerearafterintratympanicadministration
AT paavokjkinnunen biocompatibilityofliposomenanocarriersintheratinnerearafterintratympanicadministration
AT ilmaripyykko biocompatibilityofliposomenanocarriersintheratinnerearafterintratympanicadministration